COLLIGO-HCM: A Multinational Observational Study of the Real-World Effectiveness of Mavacamten Among Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

Conditions: Hypertrophic Cardiomyopathy (HCM) Interventions: Drug: Approved Hypertrophic Cardiomyopathy drug treatments; Drug: Mavacamten Sponsors: Bristol-Myers Squibb Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials